Haemonetics Reports Strong Results for Fourth Quarter and Fiscal Year End 2008 and Issues Guidance for Continued Strong Growth in F...(at http: Haemonetics Co...),Health
at http://www.haemonetics.com/investors.
Haemonetics Corporation Financial Summary
(Unaudited data in thousands, except per share data)
Consolidated Statements of Income for the Fourth Quarter FYE08
% Inc/(Dec)
3/29/08 As 3/31/07 As vs Prior
Reported Reported Year
NET REVENUES $138,739 $116,919 18.7%
Gross profit 70,141 58,346 20.2%
R&D 5,790 6,540 (11.5%)
S,G&A 44,042 31,815 38.4%
Arbitration and Settlement Income 0 (5,700) (100.0%)
In-Process R&D
Cost to Equity
Operating expenses 49,832 32,655 52.6%
Operating income 20,309 25,691 (20.9%)
Interest expense (24) (68) (64.7%)
Interest income 1,028 1,962 (47.6%)
Other income/(expense), net 69 830 (91.7%)
Income before taxes 21,382 28,415 (24.8%)
Tax expense 7,589 8,631 (12.1%)
NET INCOME $13,793 $19,784 (30.3%)
Net income per common share
assuming dilution $0.52 $0.72 (28.5%)
Weighted average number of shares
Basic 25,653 26,469
Diluted 26,602 27,313
Inc/(Dec) vs
| SOURCE Haemonetics Corporation Copyright©2008 PR Newswire. All rights reserved |
Related medicine news :
1. Haemonetics Webcast Presentation
2. Keiko Hattori Joins Haemonetics as President of Haemonetics Japan
3. Haemonetics Appoints Executive Leadership of European Operations
4. Haemonetics Sets Date for Q3FY08 Earnings Release and Conference Call - January 31, 2008
5. Haemonetics(R) Reports Strong Results for Third Quarter Fiscal 2008 with Continued Double Digit Growth in Sales
6. Haemonetics(R) Software Solutions to Launch Application for Workflow Optimization in Blood Collection Centers
7. Haemonetics Sets Date for Fourth Quarter and Fiscal Year End 2008 Earnings Release and Conference Call - May 1, 2008
8. New Study Reports High Injury Rates for Hotel Workers, Even Higher Rates for Women and Nonwhites
9. Haemacure Reports Third Quarter 2007 Results
10. First-Ever List of the 5,000 Fastest-Growing Businesses Reports Total Revenue of $194.5 Billion
11. Consumer Reports Analysis: Drugs for Nerve Pain, Fibromyalgia Effective, But Not Always Best
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |